Blundell Biotech is a U.S.-based biotechnology company with operations and earnings in a number of foreign countries. The company's profits by subsidiary, in local currency (in millions), are shown in the following table for 2013 and 2014.

The average exchange rate for each year, by currency pairs, was the following. Use this data to answer the following questions.

a. What was Blundell Biotech's consolidated profits in U.S. dollars in 2013 and 2014?
b. If the same exchange rates were used for both years, what was the change in corporate earnings on a "constant currency" basis?
c. Using the results of the 'constant currency analysis in part b, is it possible to separate Blundell's growth in earnings between local currency earnings and foreign exchange rate impacts on a consolidated basis?

Transcribed Image Text:

RussaUnited States Net IncomeSubsidry Subsidiary Subsidiary Subsidiary _Subsidiary _Subsidiary PY 1,500 GBP 100.00 EUR 204.00 CNY 168.00 RUB 124.00 USD 360.00 JPY 1,460 GBP 106.40EUR 208.00 CNY 194.00 RUB 116.00 USD 382.00 Japanese Britih European Chinese 2013 2014 Exchange Rate 2013 2014 JPY=1 USD 97.57 105.88 USD-1 GBP 1.5646 1.6473 USD=1 EUR 1.3286 1.3288 CNY=1 USD RUB-1 USD 6.1484 6.1612 31.86 38.62 USD 1.0000 1.0000